Although RAS genes are infrequently mutated in human GBM,[64, 65] they are highly expressed in glioma tissues[66] or activated in NF1‐loss GBMs,[14] leading to frequent activation of RAS pathways. The gene discussed is NF1; the disease is central nervous system cancer.